Dr Chris Seaman
Research Officer
Background
Chris completed his PhD at the Burnet Institute in 2023, with his thesis titled “Using mathematical models to guide elimination of hepatitis B as a public health”.
Chris has experience working with global stakeholders including PATH and the World Health Organization (WHO). This research has included investigation of new approaches, including the controlled temperature chain (CTC) or microarray patches (MAPs), to overcome barriers associated with delivery of the hepatitis B birth dose vaccine in low-and middle-income countries.
Chris’ current research focus is the on-going development and implementation of a dynamic hepatitis B mathematical model (designed as part of his PhD), which will be used within the 2022-2027 Vaccine Impact Modelling Consortium (VIMC).
Qualifications
- 2023: PhD, Monash University
- 2017: Master of Science (Epidemiology), University of Melbourne
- 2014: Bachelor of Biomedical Science (Honours), RMIT University
Positions
- 2023-ongoing: Research Officer, Modelling and Biostatistics
- 2020-2022: Research Assistant, Modelling and Biostatistics
Burnet publications
View 6 moreCost-effectiveness of the hepatitis B birth-dose vaccine in South Africa: a mathematical modelling analysis
The Lancet Global Health
Chris Seaman et al
A global investment case for hepatitis B elimination: a modelling study
˜The œLancet. Gastroenterology & hepatology
Chris Seaman et al
Pathway to global elimination of hepatitis B: HBV cure is just the first step
Hepatology
Jessica Howell et al
